The primary endpoint, outcome on the GBS Disability Score (GBS-DS) at 8 weeks, showed 29% of patients treated with ...

An unhealthy gut might be fuelling deadly nerve attacks. Here are diet tips to reduce the risk of Guillain-Barré Syndrome naturally.

As it advances a monoclonal antibody targeting Guillain-Barré syndrome (GBS), Annexon Biosciences is embarking on another ...

This announcement was made alongside the reveal of positive Phase 3 results for Tanruprubart, a monoclonal antibody that can block C1q and can potentially halt neuroinflammation and nerve damage in ...

Annexon achieved primary endpoints in two Phase 3 studies for tanruprubart in treating Guillain-Barre Syndrome, setting the stage for a pre-BLA meeting ...

Megyn Kelly, the American journalist, regrets her decision to get the Covid-19 vaccine, citing an autoimmune diagnosis ...

Five-year-olds can be goofy. That was my first thought several years ago when my son stumbled and fell to the ground.

Scientists have linked Zika firmly to Guillain-Barré syndrome, known for triggering temporary paralysis.

Annexon, Inc. (NASDAQ:ANNX) on Tuesday presented data for its late-stage targeted therapy, tanruprubart (formerly ANX005), ...

Far from coasting on nostalgia alone, both Christopher Cross and Toto’s appeal lies not in spectacle but in sophistication ...